Media Library

Past Presentations:

John Mascarenhas

Understanding JAK Inhibitor Treatment Strategies for Patients with Myeloproliferative Neoplasms

​​​John Mascarenhas
Associate Professor of Medicine; Myeloproliferative Disorders Program
Mount Sinai School of Medicine

Sierra Oncology

Building Momentum for Patients with Myelofibrosis

Barbara Klenke
Chief Development Officer
Sierra Oncology

University of Colorado

JAK inhibition in COVID-19

Joaquin Espinosa
Professor of Pharmacology
University of Colorado School of Medicine